Apple Inc. (AAPL) Needs Netflix, Inc. (NFLX), Einhorn Needs Patience, Investors Need Answers

Page 1 of 2

GREENLIGHT CAPITAL David EinhornI’ve been called an unabashed Apple Inc. (NASDAQ:AAPL) cheerleader. It’s a badge I wear proudly. But it’s come at a cost. Given that shares are trading at roughly 40% below its 52-week high, I’ve paid dearly. Nobody’s perfect. But somehow the market’s expectations presumed this company could execute flawlessly forever. Investors are sad to discover that this company is not being led by magicians. Admittedly, I was shocked as well. But unlike most, I’m not scorned or bitter, nor do I feel the need for revenge. Let’s have some perspective.

Has a good thing come to an end?
Lately, this has been the thought process. To that end, Apple Inc. (NASDAQ:AAPL)’s $137 billion cash hoard now offends a lot of people, one in particular being David Einhorn. There has been a deluge of articles demanding that Apple buys back stock, increase the dividend, or perform a combination thereof, with Einhorn’s so-called “iPref” proposal leading the charge. It’s a tug-of-war between Apple Inc. (NASDAQ:AAPL)’s ideals and how best to serve the interest of investors. Einhorn’s proposal and his claims are not flawless, but that’s not to say they lack merit.

Just ahead of Apple Inc. (NASDAQ:AAPL)’s annual shareholders meeting on Wednesday, a federal court sided with Einhorn’s attempt to stop the company from putting a preferred stock proposal up for vote. But publicly undermining the company doesn’t help matters. While Einhorn’s proposal talks about ways to artificially create value for shareholders, it doesn’t change sentiment. Nor does it address what is really at the center of this debate: Has a good thing come to an end? I don’t think it has. With or without iPrefs (which are said to potentially unlock $150 per share), there’s still considerable “organic” value in Apple Inc. (NASDAQ:AAPL), which is still the cheapest stock on the market.

Is the worst over or are there still execution risks?
I’m still bullish. But knowing now that Apple’s leaders are actually human, there’s also a degree of skepticism. For example, ahead of Apple’s first-quarter report, news surfaced from The Wall Street Journal that Apple had made 50% cuts to iPhone 5 orders while citing “weaker-than-expected demand.” This report coincided with concerns that the company had lost its knack for innovation, was losing its cachet to Google Inc (NASDAQ:GOOG), and was also bleeding market share to Samsung. The list was long.

Others refuted the report, calling it “old news.” But the stock still took a hit. And whether or not the news was relevant, it also brings up other potential scenarios, none of which were positive. Has Apple finally saturated the market? After all, it’s been six years since the iPhone’s debut. Management deserves credit for cutting orders (if that’s truly what it was), since there’s no point in carrying unnecessary inventory. But I do wonder why this supply/demand blockage was not anticipated sooner, especially on the heels of other gaffes related to the maps software.

These execution missteps are expected from Research In Motion Ltd (NASDAQ:BBRY) BlackBerry and Hewlett-Packard Company (NYSE:HPQ), not at Apple. As an investor, I need to know if the worst is over and if this company is truly back on track to achieving its long term potential. If not, then I have to fully support Einhorn. But I’m not there yet. And what the company reveals on Wednesday should help me decide.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!